AAAAAA

   
Results: 1-15 |
Results: 15
PREDICTORS OF EFFICACY OF ANTIARRHYTHMIC THERAPY IN PATIENTS WITH MALIGNANT VENTRICULAR TACHYARRHYTHMIAS
Authors: NESTERENKO LY BAKALOV SA EFREMOVA IY SERGIENKO VB PASHA SP GOLITSIN SP
Citation: Ly. Nesterenko et al., PREDICTORS OF EFFICACY OF ANTIARRHYTHMIC THERAPY IN PATIENTS WITH MALIGNANT VENTRICULAR TACHYARRHYTHMIAS, Kardiologia, 38(8), 1998, pp. 42-47
CHANGES OF HEART-RATE AND POWER SPECTRUM OF ITS FLUCTUATIONS INDUCED BY A SHORT-TERM COURSE OF QUINIDINE IN PATIENTS WITH VARIOUS ARRHYTHMIAS
Authors: KHAYUTIN VM BEKBOSYNOVA MS LUKOSHKOVA EV GOLITSIN SP
Citation: Vm. Khayutin et al., CHANGES OF HEART-RATE AND POWER SPECTRUM OF ITS FLUCTUATIONS INDUCED BY A SHORT-TERM COURSE OF QUINIDINE IN PATIENTS WITH VARIOUS ARRHYTHMIAS, Kardiologia, 38(1), 1998, pp. 22-30
COMPARATIVE RESULTS OF THE USE OF PROPAFE NONE AND QUINIDINE IN THE TREATMENT OF PATIENTS WITH PAROXYSMAL VENTRICULAR-TACHYCARDIA
Authors: YAKOVLEVA NV BAKALOV SA GOLITSIN SP
Citation: Nv. Yakovleva et al., COMPARATIVE RESULTS OF THE USE OF PROPAFE NONE AND QUINIDINE IN THE TREATMENT OF PATIENTS WITH PAROXYSMAL VENTRICULAR-TACHYCARDIA, Kardiologia, 38(1), 1998, pp. 31-38
STRATIFICATION OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS ACCORDING TO THE RISK OF SUDDEN-DEATH
Authors: SAVELIEVA IV BAKALOV SA GOLITSIN SP
Citation: Iv. Savelieva et al., STRATIFICATION OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS ACCORDING TO THE RISK OF SUDDEN-DEATH, Kardiologia, 37(8), 1997, pp. 82-96
CHANGES OF THE POWER OF HEART-RATE-VARIABILITY INDUCED BY PROPRANOLOLIN PATIENTS WITH CARDIAC-ARRHYTHMIAS
Authors: KHAYUTIN VM BEKBOSYNOVA MS LUKOSHKOVA EV GOLITSIN SP
Citation: Vm. Khayutin et al., CHANGES OF THE POWER OF HEART-RATE-VARIABILITY INDUCED BY PROPRANOLOLIN PATIENTS WITH CARDIAC-ARRHYTHMIAS, Kardiologia, 37(7), 1997, pp. 4-14
EFFICACY AND TOLERABILITY OF PROPAFENONE AND VERAPAMIL IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIAS
Authors: YAKOVLEVA NV ZAGRAY AA SOBOLEVA VA GOLITSIN SP
Citation: Nv. Yakovleva et al., EFFICACY AND TOLERABILITY OF PROPAFENONE AND VERAPAMIL IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIAS, Kardiologia, 37(5), 1997, pp. 11-18
ELECTROPHYSIOLOGICAL AND ANTIARRHYTHMIC E FFECTS OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN IN PATIENTS WITH PAROXYSMAL VENTRICULAR-TACHYCARDIA
Authors: MAYKOV EB BAKLANOV SA KRUTANOV IB GOLITSIN SP RUDA MY ROSENSHTRAUKH LV CHAZOV EI
Citation: Eb. Maykov et al., ELECTROPHYSIOLOGICAL AND ANTIARRHYTHMIC E FFECTS OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN IN PATIENTS WITH PAROXYSMAL VENTRICULAR-TACHYCARDIA, Kardiologia, 37(4), 1997, pp. 16-27
CLINICAL-STUDY OF NIBENTAN - NEW CLASS-II I ANTIARRHYTHMIC DRUG .2. EFFICACY IN PATIENTS WITH SUPRAVENTRICULAR ARRHYTHMIAS
Authors: RUDA MY MERKULOVA IN TARARAK AE DRAGNEV AG GOLITSIN SP ROSENSHTRAUKH LV CHAZOV EI
Citation: My. Ruda et al., CLINICAL-STUDY OF NIBENTAN - NEW CLASS-II I ANTIARRHYTHMIC DRUG .2. EFFICACY IN PATIENTS WITH SUPRAVENTRICULAR ARRHYTHMIAS, Kardiologia, 36(6), 1996, pp. 28-37
ELECTROPHYSIOLOGICAL AND ANTIARRHYTHMIC E FFECTS OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYARRHYTHMIAS
Authors: MAYKOV EB BAKALOV SA KRUTANOV IB GOLITSIN SP RUDA MY ROSENSHTRAUKH LV CHAZOV EI
Citation: Eb. Maykov et al., ELECTROPHYSIOLOGICAL AND ANTIARRHYTHMIC E FFECTS OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYARRHYTHMIAS, Kardiologia, 36(6), 1996, pp. 38-51
RESULTS OF THE USE OF ALLAPININ, AETHACIZ IN, AND BONNECOR IN TREATMENT OF PATIENTS WITH PAROXYSMAL VENTRICULAR TACHYCARDIAS UNDER INTRACARDIAC ELECTROPHYSIOLOGICAL CONTROL
Authors: PEVZNER AV BAKALOV SA MALAKHOV VI KRUTANOV IB EFREMOVA IY MAYKOV EB PANTELEYMONOV AV GOLITSIN SP
Citation: Av. Pevzner et al., RESULTS OF THE USE OF ALLAPININ, AETHACIZ IN, AND BONNECOR IN TREATMENT OF PATIENTS WITH PAROXYSMAL VENTRICULAR TACHYCARDIAS UNDER INTRACARDIAC ELECTROPHYSIOLOGICAL CONTROL, Kardiologia, 36(6), 1996, pp. 52-57
EFFICACY AND TOLERABILITY OF PROPAFENONE AND QUINIDINE IN PATIENTS WITH ATRIAL-FIBRILLATION - RESULTS OF A CROSS-OVER COMPARATIVE-STUDY
Authors: YAKOVLEVA NV ZAGRAY AA SOBOLEVA VA GOLITSIN SP
Citation: Nv. Yakovleva et al., EFFICACY AND TOLERABILITY OF PROPAFENONE AND QUINIDINE IN PATIENTS WITH ATRIAL-FIBRILLATION - RESULTS OF A CROSS-OVER COMPARATIVE-STUDY, Kardiologia, 36(4), 1996, pp. 37-41
CLINICAL INVESTIGATION OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN .1. TOLERABILITY STUDY
Authors: RUDA MY MERKULOVA IN TARARAK AE BLOKHIN AB GOLITSIN SP ROSENSHTRAUKH LV CHAZOV EI
Citation: My. Ruda et al., CLINICAL INVESTIGATION OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN .1. TOLERABILITY STUDY, Kardiologia, 35(9), 1995, pp. 4-15
PILOT EXPERIENCE IN INVESTIGATION OF ELEC TROPHYSIOLOGICAL AND ANTIARRHYTHMIC EFFECTS OF NIBENTAN IN PATIENTS WITH PAROXYSMAL TACHYARRHYTHMIAS
Authors: MAYKOV EB BAKALOV SA KRUTANOV IB GOLITSIN SP RUDA MY ROSENSHTRAUKH LV CHAZOV YI
Citation: Eb. Maykov et al., PILOT EXPERIENCE IN INVESTIGATION OF ELEC TROPHYSIOLOGICAL AND ANTIARRHYTHMIC EFFECTS OF NIBENTAN IN PATIENTS WITH PAROXYSMAL TACHYARRHYTHMIAS, Kardiologia, 35(5), 1995, pp. 10-18
COMPARATIVE ANTIARRHYTHMIC EFFICACY OF AL LAPININ, ETACIZIN AND BONNECOR IN PATIENTS WITH PAROXYSMAL VENTRICULAR-TACHYCARDIA ASSESSED BY HOLTER ECG
Authors: PEVZNER AV BAKALOV SA EFREMOVA IY KRUTANOV IB MAYKOV EB DIANOVA YF PANTELEYMONOV AV GOLITSIN SP
Citation: Av. Pevzner et al., COMPARATIVE ANTIARRHYTHMIC EFFICACY OF AL LAPININ, ETACIZIN AND BONNECOR IN PATIENTS WITH PAROXYSMAL VENTRICULAR-TACHYCARDIA ASSESSED BY HOLTER ECG, Kardiologia, 35(5), 1995, pp. 19-24
ELECTROPHYSIOLOGICAL ASPECTS OF CARDIAC A CTION OF A NEW ANTIARRHYTHMIC DRUG NIBENTAN (EXPERIMENTAL-STUDY)
Authors: ROSENSHTRAUKH LV ANYUKHOVSKY EP BELOSHAPKO GG YUSHMANOVA AV NESTERENKO VV BOGDANOV KY ZAKHAROV SI GOLOVINA VA GOLITSIN SP RUDA MY CHAZOV YI
Citation: Lv. Rosenshtraukh et al., ELECTROPHYSIOLOGICAL ASPECTS OF CARDIAC A CTION OF A NEW ANTIARRHYTHMIC DRUG NIBENTAN (EXPERIMENTAL-STUDY), Kardiologia, 35(5), 1995, pp. 25-36
Risultati: 1-15 |